What NewDays does
NewDays runs a remote cognitive-health program that pairs monthly telehealth visits with human clinicians and unlimited conversations with an AI companion named Sunny, which delivers personalized brain-training exercises between sessions. A licensed clinician oversees each patient's progress and adjusts the program over time, and the service is covered by Medicare. The company says peer-reviewed data presented at the 2026 Alzheimer's Association International Conference showed 75% of patients had improved cognitive function and dementia patients saw roughly 1.5 years of symptom-progression delay.
NewDays is a healthcare tool on Falcoscan. AI companion and telehealth program for people with mild dementia. Falcoscan rates NewDays with an Opportunity score of 84/100, a Saturation score of 11/100, and a Wrapper-risk score of 9/100. Market signal: hot. NewDays is founded in 2024, currently at Seed stage. Pricing: Paid.